•   Change Region
  • Services
  • Sustainability
  • Search

Current Activities

Securing for the Future

In November 2015, Novus announced its acquisition of the Methylmercaptopropanal (MMP) plant from Union Carbide Corporation, a subsidiary of The Dow Chemical Company, in St. Charles Parish, Louisiana, USA. MMP is a key intermediate in the manufacture of ALIMET® feed supplement. Through this acquisition, Novus now owns 100 percent of the MMP plants which supply ALIMET® production, which supports Novus’s long-term strategy in the methionine market and its commitment to its customer base.

Optimizing Shipping Processes

A project was implemented to reduce the impact of shipping a key Novus enzyme product—CIBENZA® DP100. The change was found to have the potential to reduce carbon dioxide emissions from shipping that product by over 38 percent. In the first four months of its implementation the new process saved almost 17 metric tons of carbon dioxide emissions. The impact of this change will continue to be monitored and reported on throughout 2016.

Assuring Quality Standards

An online-based computer software program was chosen to report manufacturing plant environmental sustainability data. The project will be fully implemented in 2016, allowing more streamlined use of the reported data for trend analysis, impact assessments and developing action plans.

Improving Biosecurity Measures

Novus altered its bulk-product delivery procedures to prevent spreading of the Highly Pathogenic Avian Influenza (HPAI) along with other diseases, and has implemented a 5-step set of guidelines for ensuring the safety, biosecurity and sustainability of Novus’s customers for years to come.

Streamlining Environmental Reporting

An online-based computer software program was chosen to report manufacturing plant environmental sustainability data. The project will be fully implemented in 2016, allowing more streamlined use of the reported data for trend analysis, impact assessments and developing action plans.


Action Plan

Mitigating Impacts

An Environmental, Social, and Health Impact Assessment (ESHIA) was chartered to identify any significant impacts associated with Novus’s plan to build a 120 KT ALIMET® plant in the U.S. Gulf Coast region. The ESHIA is meant to identify potential impacts of building and operating the new manufacturing facility, as well as to generate plans to mitigate the impact to the furthest extent. The assessment is expected to be complete in 2016 and supports the site selection process.

Optimizing Shipping Processes

A project was implemented to reduce the impact of shipping a key Novus enzyme product—CIBENZA® DP100. The change was found to have the potential to reduce carbon dioxide emissions from shipping that product by over 38 percent. In the first four months of its implementation the new process saved almost 17 metric tons of carbon dioxide emissions. The impact of this change will continue to be monitored and reported on throughout 2016.

Identifying Areas for Improvement

A life-cycle assessment (LCA) was chartered on a key Novus product, and will be completed in 2016. This is a milestone for the Company, displaying its dedication to ensuring that Novus delivers products that are manufactured in the most sustainable way possible. The LCA is intended to identify “hot spots” or areas for improvement in reducing the environmental impact of manufacturing Novus products.

Customer Productivity & Profitability

All of Novus’s products are designed to deliver an economic advantage to feed and animal producers.

More